Insu Hwang

425 total citations
16 papers, 281 citations indexed

About

Insu Hwang is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Insu Hwang has authored 16 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Insu Hwang's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and Viral gastroenteritis research and epidemiology (2 papers). Insu Hwang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and Viral gastroenteritis research and epidemiology (2 papers). Insu Hwang collaborates with scholars based in South Korea, Japan and United States. Insu Hwang's co-authors include Kyun‐Do Kim, Gun Young Yoon, Young‐Chan Kwon, Sumin Lee, Gi Uk Jeong, Kenichiro Mori, Katsuki Ohtani, Y. Matsuda, Nitai Roy and Nobutaka Wakamiya and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochimica et Biophysica Acta (BBA) - General Subjects and Experimental & Molecular Medicine.

In The Last Decade

Insu Hwang

14 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Insu Hwang South Korea 10 116 76 75 67 48 16 281
Kathy Manguiat Canada 9 281 2.4× 224 2.9× 62 0.8× 38 0.6× 78 1.6× 14 573
Vincent Francis Canada 5 227 2.0× 118 1.6× 56 0.7× 54 0.8× 11 0.2× 6 369
Guanqin Ma China 5 88 0.8× 152 2.0× 129 1.7× 25 0.4× 63 1.3× 7 295
Bariaa Khalil United Arab Emirates 7 126 1.1× 149 2.0× 93 1.2× 70 1.0× 7 0.1× 12 336
Dinesh Kabra India 10 129 1.1× 82 1.1× 58 0.8× 34 0.5× 81 1.7× 12 395
Tingting Zheng China 3 258 2.2× 93 1.2× 87 1.2× 47 0.7× 6 0.1× 6 371
Caio Perez Gomes Brazil 9 65 0.6× 79 1.0× 69 0.9× 19 0.3× 5 0.1× 20 359
Natalia Zamorano Cuervo Canada 7 198 1.7× 124 1.6× 80 1.1× 58 0.9× 5 0.1× 13 380
Monireh Kamali Iran 6 178 1.5× 81 1.1× 29 0.4× 93 1.4× 6 0.1× 30 312

Countries citing papers authored by Insu Hwang

Since Specialization
Citations

This map shows the geographic impact of Insu Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Insu Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Insu Hwang more than expected).

Fields of papers citing papers by Insu Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Insu Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Insu Hwang. The network helps show where Insu Hwang may publish in the future.

Co-authorship network of co-authors of Insu Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Insu Hwang. A scholar is included among the top collaborators of Insu Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Insu Hwang. Insu Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Jeong, Gi Uk, Insu Hwang, Ji Hyun Choi, et al.. (2024). Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis. Experimental & Molecular Medicine. 56(5). 1221–1229. 4 indexed citations
3.
Baek, Jin Yang, Kyungmin Huh, Sun Young Cho, et al.. (2023). Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023. Journal of Korean Medical Science. 38(27). e205–e205. 1 indexed citations
4.
Jeong, Gi Uk, Jaemyun Lyu, Kyun‐Do Kim, et al.. (2022). SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death. Microbiology Spectrum. 10(3). e0109122–e0109122. 90 indexed citations
5.
Seok, Jeong Ho, Insu Hwang, Jared Adolf‐Bryfogle, et al.. (2022). Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants. mAbs. 14(1). 13 indexed citations
6.
Jeong, Gi Uk, Gun Young Yoon, Insu Hwang, et al.. (2021). Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern. Viruses. 14(1). 55–55. 14 indexed citations
7.
Shin, Hye Jin, Keun Bon Ku, Hae Soo Kim, et al.. (2021). Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung. International Journal of Biological Sciences. 17(14). 3786–3794. 11 indexed citations
8.
Valiente, Pedro A., Han Wen, Satra Nim, et al.. (2021). Computational Design of Potent D-Peptide Inhibitors of SARS-CoV-2. Journal of Medicinal Chemistry. 64(20). 14955–14967. 47 indexed citations
9.
Shin, Hye Jin, Mi-Hwa Kim, Joo‐Youn Lee, et al.. (2021). Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses. Microorganisms. 9(3). 545–545. 20 indexed citations
10.
Kim, Kyun‐Do, Insu Hwang, Keun Bon Ku, et al.. (2020). Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses. Journal of Microbiology and Biotechnology. 30(8). 1109–1115. 8 indexed citations
11.
Hwang, Insu, Kenichiro Mori, Katsuki Ohtani, et al.. (2017). Collectin Kidney 1 Plays an Important Role in Innate Immunity against <b><i>Streptococcus pneumoniae</i></b> Infection. Journal of Innate Immunity. 9(2). 217–228. 20 indexed citations
12.
Roy, Nitai, Katsuki Ohtani, Yoshihiko Hidaka, et al.. (2016). Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 1–14. 20 indexed citations
13.
Roy, Nitai, Katsuki Ohtani, Y. Matsuda, et al.. (2016). Collectin CL-P1 utilizes C-reactive protein for complement activation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(6). 1118–1128. 18 indexed citations
14.
Matsuda, Y., Katsuki Ohtani, Nitai Roy, et al.. (2016). Structural characterization of novel collectins, CL-K1, CL-L1, and CL-LK in blood. Immunobiology. 221(10). 1215–1215.
15.
Hwang, Insu, K. Mori, Katsuki Ohtani, et al.. (2016). In vitro and in vivo roles in Collectin Kidney 1 (CL-K1) with innate immunity against Streptococcus pneumoniae. Immunobiology. 221(10). 1217–1217. 1 indexed citations
16.
Mori, Kenichiro, Katsuki Ohtani, Seongjae Jang, et al.. (2014). Scavenger receptor CL-P1 mainly utilizes a collagen-like domain to uptake microbes and modified LDL. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(12). 3345–3356. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026